Search research articles
Contact Us
Filters
Showing results (11-20 of 344) with videos related to
Page
of 35
Sort By:
Molecular & Cellular Proteomics : MCP
|
May 31, 2006
Proteomics of breast cancer: principles and potential clinical applications
François Bertucci, Daniel Birnbaum, Anthony Goncalves
Cancer Cell International
|
June 29, 2013
Signaling pathway switch in breast cancer
Arnaud Guille, Max Chaffanet, Daniel Birnbaum
Pediatric Neurology
|
April 19, 2014
Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity
Maryam Afshar, Daniel Birnbaum, Carla Golden
Chinese Clinical Oncology
|
January 8, 2017
An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures
François Bertucci, Max Chaffanet, Daniel Birnbaum
The New England Journal of Medicine
|
May 4, 2007
A gene signature in breast cancer
Francois Bertucci, Nathalie Cervera, Daniel Birnbaum
The Lancet. Oncology
|
June 18, 2016
SPAG5: the ultimate marker of proliferation in early breast cancer?
François Bertucci, Patrice Viens, Daniel Birnbaum
Oncoscience
|
August 5, 2016
XPO1, therapeutic … and prognostic target in sarcomas
François Bertucci, Pascal Finetti, Daniel Birnbaum
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
December 23, 2004
A pair as a minimum: the two fibroblast growth factors of the nematode Caenorhabditis elegans
Daniel Birnbaum, Cornel Popovici, Régine Roubin
Breast Cancer Research : BCR
|
April 19, 2015
The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
François Bertucci, Pascal Finetti, Daniel Birnbaum
Frontiers of Neurology and Neuroscience
|
October 19, 2018
Thomas Mann and Neurology
Nicoletta Caputi, Daniel Birnbaum, François Boller
Page
of 35
Search research articles
Search
Showing results (11-20 of 344) with videos related to
Sort By:
Page
of 35
Molecular & Cellular Proteomics : MCP
|
May 31, 2006
Proteomics of breast cancer: principles and potential clinical applications
François Bertucci, Daniel Birnbaum, Anthony Goncalves
Cancer Cell International
|
June 29, 2013
Signaling pathway switch in breast cancer
Arnaud Guille, Max Chaffanet, Daniel Birnbaum
Pediatric Neurology
|
April 19, 2014
Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity
Maryam Afshar, Daniel Birnbaum, Carla Golden
Chinese Clinical Oncology
|
January 8, 2017
An ICGC major achievement in breast cancer: a comprehensive catalog of mutations and mutational signatures
François Bertucci, Max Chaffanet, Daniel Birnbaum
The New England Journal of Medicine
|
May 4, 2007
A gene signature in breast cancer
Francois Bertucci, Nathalie Cervera, Daniel Birnbaum
The Lancet. Oncology
|
June 18, 2016
SPAG5: the ultimate marker of proliferation in early breast cancer?
François Bertucci, Patrice Viens, Daniel Birnbaum
Oncoscience
|
August 5, 2016
XPO1, therapeutic … and prognostic target in sarcomas
François Bertucci, Pascal Finetti, Daniel Birnbaum
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
December 23, 2004
A pair as a minimum: the two fibroblast growth factors of the nematode Caenorhabditis elegans
Daniel Birnbaum, Cornel Popovici, Régine Roubin
Breast Cancer Research : BCR
|
April 19, 2015
The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
François Bertucci, Pascal Finetti, Daniel Birnbaum
Frontiers of Neurology and Neuroscience
|
October 19, 2018
Thomas Mann and Neurology
Nicoletta Caputi, Daniel Birnbaum, François Boller
Page
of 35